We propose that 3hi2one-G4 could serve as a useful pharmaceutical probe in studying GIRK4 channel function and may also be pursued in drug optimization studies to tackle GIRK4-related diseases such as primary aldosteronism and late-onset obesity. The gene discussed is KCNJ5; the disease is obesity due to melanocortin 4 receptor deficiency.